Figures and Tables

From the following article:

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

The Cancer Genome Atlas Research Network

Nature 455, 1061-1068(23 October 2008)

doi:10.1038/nature07385

BACK TO ARTICLE
Figure 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 1

Significant copy number aberrations and pattern of somatic mutations.

Full size figure and legend (176K)Download PowerPoint slide (558K)
Figure 2 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 2

Mutations in NF1 tumour suppressor gene and EGFR family members.

Full size figure and legend (201K)Download PowerPoint slide (766K)
Figure 3 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 3

PIK3R1 and PIK3CA mutations in glioblastoma.

Full size figure and legend (241K)Download PowerPoint slide (824K)
Figure 4 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 4

Pattern of somatic mutations, MGMT DNA methylation and MMR gene mutations in treated glioblastomas.

Full size figure and legend (129K)Download PowerPoint slide (512K)
Figure 5 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 5

Frequent genetic alterations in three critical signalling pathways.

Full size figure and legend (232K)Download PowerPoint slide (744K)

Slides may be downloaded for educational use, according to the terms described in Nature Publishing Group's licensing policy.

BACK TO ARTICLE